Attention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They examine in detail projects that have commercial potential or products that have already been commercialized, illustrating the advantages that plants offer over bacterial, fungal or animal cell-culture hosts.?There are many indications that plant protein production marks the beginning of a new paradigm for the commercial production of proteins that, over the next decade, will expand dramatically.
1 Introduction Plant-produced protein products
Elizabeth E. Hood and Paul Christou
Part I: Highly Purified Proteins
2 Commercial Plant-Produced Recombinant Avidin
Elizabeth E. Hood and John A. Howard
3 Molecular farming in plants the long road to the market
Rainer Fischer, Johannes F Buyel, Stefan Schillberg and Richard M Twyman
4 TrypZean : an animal-free alternative to bovine trypsin
Aparna Krishnan, Susan L. Woodard
5 Production of Pharmaceutical Grade Recombinant Native Aprotinin and Non-Oxidized Aprotinin-Variants Under Greenhouse and Field Conditions
Gregory P. Pogue, Fakhrieh Vojdani, Kenneth E. Palmer, Earl White, Hugh Haydon, Barry Bratcher
Part II: Vaccines
6 Influenza virus-like particles produced in Nicotiana benthamiana protect against a lethal viral challenge in mice
Louis-P V?zina, Brian J Ward, Marc-Andr? DAoust, Manon Couture, Sonia Tr?panier, Andrew Sheldon1, Nathalie Landry
7 Plant-Produced Recombinant Transmission Blocking Vaccine Candidates to Combat Malaria
Stephen J. Streatfield, NatashalS